$TAK

$20.40▲ +0.1% YTD

1 SEC 13D/G filing tracked · Last updated Oct 23, 2026

Filing History

TAK ▲ +0.1% - Takeda Pharmaceutical Company Limited

CP $20.40▲ +0.1%Oct 23, 2026 · ThinkSabio Blog

$TAK Takeda: Phase 3 Gastric Cancer Trial Meets Both Primary Endpoints, Reducing Risk of Death by 43% ? • Overall Survival: Median 10.2 months vs. 6.9…